DJIA 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%

Novartis

NYSE: NVS

74.15 -0.86 (-1.15%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVS $74.15 -1.15%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $73.53
Previous Close $75.01
Daily Range $73.50 - $74.16
52-Week Range $51.20 - $75.67
Market Cap $182.2B
P/E Ratio 19.28
Dividend (Yield) $2.53 (2.7%)
Ex-Dividend Date
Dividend Pay Date
02/26/13
04/05/13
Volume 1,092,063
Average Daily Volume 1,481,047
Current FY EPS $5.11

Sector

Healthcare

Industry

Drugs

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/

News & Commentary Rss Feed

Novartis AG (NVS): Today's Featured Drugs Laggard

3 Companies That Put the "Tech" in "Biotech"

From 3-D modeling to tamper-resistant drugs to personalized genomics, these companies put the "tech" in "biotech."

Novartis Considers Possible Bid for Actavis

Angelina Jolie's Selfless Act Heightens Breast Cancer Awareness

Jolie's personal experiences brings the dangers of breast cancer into new light and also gives hope to current and future breast cancer sufferers thanks to improving therapies and diagnostic tests.

Good News for Novartis' Ilaris - Analyst Blog

Good News for Novartis' Ilaris - Analyst Blog

Why Bristol-Myers Is Soaring

The speculation centers around Bristol-Myers' cancer trial results.

Novartis Reaches New 52-Week High (NVS)

Aveo Screwed Up but Its Kidney Cancer Drug Is Real

Array Biopharma: Measuring The Strength Of This Small-Cap Pharma Stock

The Hidden Opportunity of the Novel Coronavirus

With the potential for an epidemic at hand, we look at things from a glass-half-full perspective.

See More NVS News...

NVS's Top Competitors

NVS $74.15 (-1.15%)
Current stock: NVS
JNJ $88.09 (0.73%)
Current stock: JNJ
PFE $28.96 (-0.99%)
Current stock: PFE
MRK $45.99 (-0.82%)
Current stock: MRK